Avastin
What’s In The News: July 21st, 2010
Roche provides update from Avastin FDA advisory committee meeting
Morning Market Snapshot: Apache Corp to Acquire Assets from BP
foodconsumer.org – Fish Oil, not Avastin, Fights Breast Cancer
Early media reports say that Avastin made by Roche does not give breast cancer patients any benefits. It has been used for a few years, FDA advisers now say this drug should not be used as a treatment for breast cancer. …
Experts Veto Avastin As Breast Cancer Drug – Health News Story …
GAITHERSBURG — A panel of cancer experts say that the government should remove its endorsement of Roche’s drug Avastin for breast cancer, after studies failed to show benefits for patients. Wednesday, July 21, 2010.
Large 'real-world' study shows Avastin-based therapy extends …
New data show that Avastin (bevacizumab) based therapy provides a median overall survival (OS) of 14.6 months with a range of chemotherapies routinely used in clinical practice and in a broad population of patients with advanced …
Experts Veto Genentech's Avastin For | Top Industry News …
A panel of cancer experts said Tuesday that the government should remove its endorsement of Genentech’s drug Avastin for breast cancer, after follow-up studies failed to show benefits for patients. A Food and Drug Administration panel …
Advisory Panel Will Not Recommend Avastin For Breast Cancer : dBTechno
The FDA will now rule on whether or not to follow in the footsteps of their advisory panel and revoke Avastin, which would mean a huge financial loss going forward for Roche. Share and Enjoy: These icons link to social bookmarking sites …
 |
mariagoreth says: Published a new post: Experts knock back cancer drug Avastin http://cancer.blogam.info/experts-knock-back-cancer-drug-avastin |
 |
EPVantage says: Avastin adcom decision a warning for Roche . http://bit.ly/9wXVDy $ROG #pharma #FDA |
 |
mybestbody says: Breast Cancer Drug Avastin Approval Withdrawn by FDA Panel http://dlvr.it/2sjBw #health #fitness #body #life #yoga |
 |
BreastCancerRe says: Roche shares down 4 percent after US panel cites negative studies on Avastin http://bit.ly/c1bw4Q |
 |
MautnerProject says: RT @BrstCancerNews: Google News: Avastin Rejected as Breast Cancer Treatment – LA Times http://bit.ly/9sEMsM Full http://bit.ly/b4hEEM |
 |
peelbackthepink says: FDA advisory committee votes to revoke approval of #Avastin for metastatic breast cancer patients – http://bit.ly/AvastinKBC |
 |
ThePharmaLetter says: US FDA advisory panel votes to withdraw approval for Roches' Avastin breast cancer treatment http://bit.ly/9YUOQ3 #pharma #cancer |
 |
burrillreport says: Roche could lose $1 billion in revenue if FDA follows panel recommendation to revoke Avastin approval in breast… http://fb.me/tGWgWJDc |
This entry was posted on Wednesday, July 21st, 2010 at 6:03 pm and is filed under News, Trends. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
